Exicure, inc. (nasdaq: xcur) announces their next step in planning for a new clinical trial in acute myeloid leukemia (aml)

Redwood city, calif.--(business wire)--exicure, inc. announces their next step in planning for a new clinical trial in acute myeloid leukemia (aml).

XCUR Ratings Summary

XCUR Quant Ranking